Innovative Treatment Modalities
Identifying the Breast Cancer Target for
Indole-3-Carbinol
Chatterji, Urmi
University of California, Berkeley
2 years, $80,000
Targeted Delivery of an Anti-breast
Tumor Agent
Fujii, Gary
Molecular Express, Inc.,
Hall, Fred L,
Markland, Francis S
University of Southern California
2 years, $684,996
Role of p14ARF in Metastatic Breast
Cancer
Gjerset, Ruth A
Sidney Kimmel Cancer Center
2 years. $383,800
Wnt Signaling in Breast Cancer:
Translational Studies
Holcombe, Randall F,
Marsh, J. Lawrence,
Waterman, Marian L
University of California, Irvine
2 years, $328,129
Cell-Based Immunotherapy for Breast
Cancer
Jabrane-Ferrat, Nabila
University of California, San Francisco
2 years, $125,371
Novel Agents for Treatment of Advanced
Breast Cancer
Jong, Ling
SRI International
2 years, $390,894
Novel Anti-Angiogenic Agents for Breast
Cancer Therapy
Laderoute, Keith R
SRI International
2 years, $372,372
Stress Protein and Drug Resistance in
Human Breast Cancer
Lee, Amy S
University of Southern California
2 years, $326,000
Computer-Aided Discovery of Novel Breast
Cancer Therapeutics
Dawson, Marcia I,
Loew, Gilda
Molecular Medicine Research Institute
1 year, $147,232
A New Class of Drugs to Treat Breast Cancer
Robertson, Thomas
University of California, San Francisco
2 years, $80,000
Arginine Deiminase as an Innovative Anti-
Breast Cancer Agent
Shen, Wei-Chiang
University of Southern California
1 year, $81,750
Thrombosis for Anti-angiogenicTherapy of
Breast Cancer
Su, Min-Ying L
University of California, Irvine
2 years, $200,000
Targeted Chemotherapy to Treat Breast
Cancer
Szoka, Francis C
University of California, San Francisco
2 years, $200,000
* Chinese Herbal Therapy (CHT) for Symptom
Management
Tripathy, Debasish
University of California, San Francisco
2 years, $200,000
Tea Polyphenol Analogs for Breast
Cancer Chemoprevention
Zaveri, Nurulain T
SRI International
2 years, $295,015
* Tax Check-off Award
